CDNF Antikörper
-
- Target Alle CDNF Antikörper anzeigen
- CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CDNF Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- Human, CDNF protein
- Aufreinigung
- purified by protein G affinity chromatography
- Immunogen
- Recombinant human CDNF protein produced usingCHO-based Icosagen Cell factory Ltd. proprietary suspension cell line. Purifiedfrom cell culture supernatant
- Klon
- 7D6
- Isotyp
- IgG1
- Top Product
- Discover our top product CDNF Primärantikörper
-
-
- Applikationshinweise
- ELISA: 1:64 000, WB: 1:4000. Monoclonal antibody working titer has to be established practically for each particular antigen and assay format
- Kommentare
-
Synonym: ARMETL1
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/ml
- Buffer
- PBS pH 7.4, with 0.1%
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Divide antibodyinto aliquots prior usage. Avoid multiple freeze-thaw cycles as productdegradation may result.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- This product is shipped in non-frozen liquid form in ambient conditions
-
-
Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy." in: Cell transplantation, Vol. 28, Issue 4, pp. 413-424, (2020) (PubMed).
: "
-
Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy." in: Cell transplantation, Vol. 28, Issue 4, pp. 413-424, (2020) (PubMed).
-
- Target
- CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))
- Andere Bezeichnung
- CDNF (CDNF Produkte)
- Synonyme
- ARMETL1 antikoerper, 9330140G23 antikoerper, Armetl1 antikoerper, cerebral dopamine neurotrophic factor antikoerper, CDNF antikoerper, Cdnf antikoerper
- Hintergrund
- CDNF is a trophic factor for midbrain dopamine neuronsin vivo. It prevents the 6-OHDA- (Lindholmet al. 20007, Voutilainen et al., 2011) and MPTP-induced degeneration(Airavaara et al., 2012) of dopamine neurons in rodent models of Parkinson’sdisease. When administered after 6-OHDA or MPTP –lesioning it restores thedopaminergic function and prevents degeneration of dopamine neurons insubstantia nigra pars compacta
- UniProt
- Q49AH0
-